TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 35 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,090,080 | +386.3% | 747,442 | +368.4% | 0.00% | – |
| Q1 2024 | $1,046,793 | +3.0% | 159,572 | +1.9% | 0.00% | – |
| Q4 2023 | $1,016,542 | +70.3% | 156,632 | +32.0% | 0.00% | – |
| Q3 2023 | $596,960 | -61.3% | 118,680 | -32.6% | 0.00% | -100.0% |
| Q2 2023 | $1,541,207 | +3484.2% | 176,138 | +1137.2% | 0.00% | – |
| Q1 2022 | $43,000 | -48.2% | 14,237 | 0.0% | 0.00% | – |
| Q4 2021 | $83,000 | -44.7% | 14,237 | 0.0% | 0.00% | – |
| Q3 2021 | $150,000 | -14.3% | 14,237 | 0.0% | 0.00% | – |
| Q2 2021 | $175,000 | -43.5% | 14,237 | +1.1% | 0.00% | – |
| Q1 2021 | $310,000 | – | 14,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUPERSTRING CAPITAL MANAGEMENT LP | 956,542 | $6,514,051 | 8.21% |
| Vivo Capital, LLC | 6,182,992 | $42,106,176 | 3.89% |
| Soleus Capital Management, L.P. | 4,947,738 | $33,694,096 | 2.97% |
| ACUTA CAPITAL PARTNERS, LLC | 369,280 | $2,514,797 | 2.12% |
| GREAT POINT PARTNERS LLC | 1,149,406 | $7,827,455 | 1.50% |
| VR Adviser, LLC | 3,410,058 | $23,222,495 | 1.48% |
| Octagon Capital Advisors LP | 1,364,400 | $9,291,564 | 1.46% |
| Deep Track Capital, LP | 6,100,000 | $41,541,000 | 1.24% |
| Orbimed Advisors | 7,619,135 | $51,886,309 | 1.02% |
| Worth Venture Partners, LLC | 17,470 | $118,971 | 0.88% |